Intensity modulated radiation therapy (IMRT) as an alternative to adjuvant high dose rate (HDR) brachytherapy in endometrial cancer patients

被引:0
|
作者
Wang, S [1 ]
Smith, B [1 ]
Sutton, H [1 ]
Aydogan, B [1 ]
Mundt, A [1 ]
Roeske, J [1 ]
机构
[1] Univ Chicago, Chicago, IL 60637 USA
关键词
D O I
10.1118/1.1997475
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the role of IMRT as an alternative to HDR brachytherapy for the adjuvant treatment of endometrial cancer patients following surgery. Method and Materials: The CT scans of five patients previously treated with adjuvant HDR were used in this study. All patients were scanned with a vaginal cylinder in place, and HDR planning was performed using the BrachyVision (Varian Medical Systems) software. In all cases, a dose of 700 cGy/fraction was prescribed at a distance of 0.5 cm from the cylinder surface. The same planning CT scans were then used for IMRT planning (Eclipse, Varian Medical Systems). In this paradigm, the vaginal cylinder is a component of a hypothetical immobilization system that would be indexed to the linac treatment table. The goal of IMRT planning was to deliver the prescription dose to the clinical target volume (CTV) while minimizing the volume of rectum and bladder irradiated. Dose volume histograms (DVHs) of the bladder, rectum and CTV were recorded and compared for both HDR and IMRT plans. Results: The mean bladder doses (as a percentage of the prescription dose) were 31.8% and 32.2% (p = 0.93) for the HDR and IMRT plans, respectively. However, in 4 of the 5 plans, IMRT produced lower maximum bladder doses compared to HDR (averages: IMRT = 99.1% vs. HDR = 158.4%). IMRT plans also resulted in lower mean rectal doses (21.6%) than HDR plans (30.9%) (p = 0.01). Moreover, the maximum rectal doses were lower in all IMRT plans compared to the HDR plans (95.1% vs. 165.8%). On average, the minimum dose to CTV was slightly higher using IMRT (97.8% vs. 95.5%). Conclusion: These results suggest than when used in conjunction with a suitable immobilization system, IMRT may provide an alternative to HDR brachytherapy in women with endometrial cancer following hysterectomy. © 2005, American Association of Physicists in Medicine. All rights reserved.
引用
收藏
页码:1902 / 1903
页数:2
相关论文
共 50 条
  • [1] A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients
    Aydogan, Bulent
    Mundt, Arno J.
    Smith, Brett D.
    Mell, Loren K.
    Wang, Steve
    Sutton, Harold
    Roeske, John C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (01): : 266 - 273
  • [2] Dosimetric Comparison of High Dose Rate (HDR) Brachytherapy and Intensity Modulated Radiation Therapy (IMRT) for Rectal Adenocarcinoma
    Parekh, A.
    Le, Y.
    Duhon, M.
    Kummerlowe, M.
    Herman, J. M.
    Hobbs, R. F.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E178 - E178
  • [3] Intensity Modulated Radiation Therapy (IMRT), High Dose Rate Brachytherapy (HDR) and Weekly Cisplatinum (CDDP) for Treatment of Locally Advanced Cervical Cancer (LACC)
    Thawani, N.
    Kabarriti, R.
    Gao, W.
    Vainshtein, J.
    Yaparpalvi, R.
    Mehta, K. J.
    Skinner, W. J.
    Einstein, M.
    Kalnicki, S.
    Mutyala, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S358 - S359
  • [4] Outcomes of Asian patients with localized prostate cancer treated with combined intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy: A single institution experience
    Ng, Ivy Wei Shan
    Tey, Jeremy Chee Seong
    Soon, Yu Yang
    Tseng, Michelle Shu Fen
    Chen, Desiree
    Lim, Keith Hsiu Chin
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (05) : e386 - e391
  • [5] Preliminary Results in Prostate Cancer Patients Treated with High Dose Rate Brachytherapy and Intensity Modulated Radiation Therapy (IMRT) vs. IMRT Alone
    Wilder, R. B.
    Barme, G. A.
    Gilbert, R. F.
    Holevas, R. E.
    Kobashi, L. I.
    Reed, R. R.
    Solomon, R. S.
    Walter, N. L.
    Chittenden, L.
    Tokita, K. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S340 - S340
  • [6] Comparison of high dose rate (HDR) vs intensity modulated radiation therapy (IMRT) for prostate boost treatment
    Bose, S
    Huq, M
    Bahri, S
    Lalonde, R
    Selvaraj, R
    Brandner, E
    Yue, N
    [J]. MEDICAL PHYSICS, 2005, 32 (06) : 2107 - 2107
  • [7] INTERSTITIAL HIGH DOSE RATE (HDR) BRACHYTHERAPY plus INTENSITY MODULATED RADIATION THERAPY (IMRT) VS. HDR MONOTHERAPY FOR EARLY STAGE PROSTATE CANCER : A REPORT OF 357 CASES
    Steven, G.
    Mark, R.
    Anderson, P.
    Neumann, T.
    Nair, M.
    White, D.
    Akins, R.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S107 - S107
  • [8] Preliminary results in prostate cancer patients treated with high-dose-rate brachytherapy and intensity modulated radiation therapy (IMRT) vs. IMRT alone
    Wilder, Richard B.
    Barme, Greg A.
    Gilbert, Ronald F.
    Holevas, Richard E.
    Kobashi, Luis I.
    Reed, Richard R.
    Solomon, Ronald S.
    Walter, Nancy L.
    Chittenden, Lucy
    Mesa, Albert V.
    Agustin, Jeffrey K.
    Lizarde, Jessica
    Macedo, Jorge C.
    Ravera, John
    Tokita, Kenneth M.
    [J]. BRACHYTHERAPY, 2010, 9 (04) : 341 - 348
  • [9] Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer
    Contreras, Jessika
    Srivastava, Amar
    Chundury, Anupama
    Schwarz, Julie K.
    Markovina, Stephanie
    Thaker, Premal H.
    Massad, L. Stewart
    Mutch, David G.
    Powell, Matthew A.
    Grigsby, Perry W.
    Lin, Alexander J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (08) : 1157 - 1161
  • [10] Endometrial cancer recurrence: Adjuvant high-dose rate vaginal brachytherapy (HDR) versus HDR with whole pelvic radiation.
    Villella, Jeannine A.
    Palaia, Thomas
    Chalas, Eva
    Patrick, Patricia
    Haas, Jonathan A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)